Sage Journals: Discover world-class research

Free access

Review article

First published 2016-7

Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection

Ignasi Puig, Sheila López-Góngora, Xavier Calvet [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2018-8-1

Optimal First-Line Treatment of Metastatic Renal-Cell Carcinoma: A Network Meta-Analysis

Andrew W. Hahn, Peter Hale, Benjamin L. Maughan [...]

Kidney Cancer

Free access

Case report

First published 2013-7

Optimizing Treatment Switch for Virologic Failure during First-Line Antiretroviral Therapy in Resource-Limited Settings

Adedotun A. Adetunji, Chad Achenbach, Joseph Feinglass [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Retricted access

Research article

First published 1994-12

An Intensive Treatment with Mitoxantrone and Ifosfamide in Second-Line Therapy of Epithelial Ovarian Cancer

Angelo Di Leo, Laura Biganzoli, Silvia Bohm [...]

Tumori Journal

Retricted access

Research article

First published 2020

Voting Lines,Equal Treatment,and Early Voting Check-In Times in Florida

David Cottrell, Michael C. Herron, Daniel A. Smith

State Politics & Policy Quarterly

Retricted access

Research article

First published 2015-3

Tivantinib,a New Option for Second-line Treatment of Advanced Hepatocellular Carcinoma? The Experience of Italian Centers

Lorenza Rimassa, Armando Santoro, Bruno Daniele [...]

Tumori Journal

Retricted access

Research article

First published 2021-12

Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer

Zenta Seto, Naoki Takata, Nozomu Murayama [...]

Tumori Journal

Open access

Review article

First published 2023

Update on the second-line treatment of Helicobacter pylori infection: a narrative review

Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2020

Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer

Takahiro Ishii, Akihito Kawazoe, Akinori Sasaki [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program

Pupe Sudsila, Sirinya Teeraananchai, Sasisopin Kiertiburanakul [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Search results